ConductScience.org, home

Paper19787312

Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer.

Iwano S and 5 others. Ann Nucl Med, 2009. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer. Papers, record 19787312. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19787312

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer.
PubMed
Journal
Ann Nucl Med
PubMed
Year
2009
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
0.95
iCite
Revised in PubMed
2016-11-25
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iwano SShingo
2Kato KKatsuhiko
3Nihashi TTakashi
4Ito SShinji
5Tachi YYasushi
6Naganawa SShinji

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neoplasm MetastasisMajor topic
Thyroid GlandMajor topic
Thyroid NeoplasmsMajor topic
Adolescent
Adult
Aged
Female
Humans
Iodine Radioisotopes
Male
Middle Aged
Radiation Dosage
Radionuclide Imaging
Whole Body Imaging
Young Adult

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
42572024
Optimal timing of post-therapeutic [131I]NaI whole-body scintigraphy in predominantly low- and intermediate-risk differentiated thyroid cancer: a secondary analysis of prospectively acquired data and a structured literature review.
BMC Med Imaging2026https://conductscience.org/library/papers/42572024PubMed
41718114The Role of 123I in the Management of Differentiated Thyroid Cancer: A Comprehensive Narrative Review.Med Sci (Basel)2026https://conductscience.org/library/papers/41718114PubMed
41515514Prediction of Treatment Response by Thyroid Bed Uptake on Post-Ablative Whole-Body Scan in Intermediate-Risk Patients with Papillary Thyroid Cancer.Diagnostics (Basel)2025https://conductscience.org/library/papers/41515514PubMed
40003609A Method for Calculating Small Sizes of Volumes in Postsurgical Thyroid SPECT/CT Imaging.Life (Basel)2025https://conductscience.org/library/papers/40003609PubMed
39941793Current and Emerging Radiotracers and Technologies for Detection of Advanced Differentiated Thyroid Cancer: A Narrative Review.Cancers (Basel)2025https://conductscience.org/library/papers/39941793PubMed
37109490A Neck-Thyroid Phantom with Small Sizes of Thyroid Remnants for Postsurgical I-123 and I-131 SPECT/CT Imaging.Life (Basel)2023https://conductscience.org/library/papers/37109490PubMed
36839858Evaluation of Therapeutic Efficacy and Imaging Capabilities of 153Sm2O3-Loaded Polystyrene Microspheres for Intra-Tumoural Radionuclide Therapy of Liver Cancer Using Sprague-Dawley Rat Model.Pharmaceutics2023https://conductscience.org/library/papers/36839858PubMed
36093082A semiquantitative study of the optimal whole-body imaging time after 131I therapy for differentiated thyroid cancer.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36093082PubMed
29531251Predicting 131I-avidity of metastases from differentiated thyroid cancer using 18F-FDG PET/CT in postoperative patients with elevated thyroglobulin.Sci Rep2018https://conductscience.org/library/papers/29531251PubMed
29086115Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond.Med Oncol2017https://conductscience.org/library/papers/29086115PubMed
26897715Novel Approaches to Thyroid Cancer Treatment and Response Assessment.Semin Nucl Med2016https://conductscience.org/library/papers/26897715PubMed
26085858Relations Between Pathological Markers and Radioiodine Scan and (18)F-FDG PET/CT Findings in Papillary Thyroid Cancer Patients With Recurrent Cervical Nodal Metastases.Nucl Med Mol Imaging2015https://conductscience.org/library/papers/26085858PubMed
23724150Clinical significance of discordant findings between pre-therapy (123)I and post-therapy (131)I whole body scan in patients with thyroid cancer.Int J Clin Exp Med2013https://conductscience.org/library/papers/23724150PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19787312

GET https://conductscience.org/api/papers/v1/19787312/authors